Back

Corrigendum to: Predicted Benefit of an Implantable Cardioverter-Defibrillator: The MADIT-ICD Benefit Score

European Heart Journal

7 February 2021
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Arrhythmias, General HEART FAILURE Chronic Heart Failure Atrial Fibrillation (AF) Device Therapy PREVENTIVE CARDIOLOGY Risk Factors and Prevention Supraventricular Tachycardia (Non-Atrial Fibrillation)
You may be interested in
thumbnail
Congress Presentation
Impact of ICD implantation in heart failure patients for primary prevention of sudden cardiac death: the real usefulness of the MADIT-ICD benefit score.
22 May 2023
thumbnail
Congress Presentation
Optimizing patient selection for cardiac resynchronization therapy in a multicenter study of Japanese patients: assessment of the MADIT-ICD benefit group
30 August 2024
thumbnail
Congress Session
Arrhythmias and devices
17 May 2025
thumbnail
Congress Presentation
Implantable Cardioverter-Defibrillator - do we have alternative predictors to administered shocks?
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources